Cleared Traditional

K113277 - ARROWADVANTAGES PRESSURE INJECTABLE PERIPHERALLY INSCRTED CENTRAL CATHETER KITS

K113277 is an FDA 510(k) clearance for ARROWADVANTAGES PRESSURE INJECTABLE PER..., manufactured by Arrow International, Inc.. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 227-day FDA review.

K113277 · Arrow International, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
227d
Days
Class 2
Risk

K113277 is an FDA 510(k) clearance for the ARROWADVANTAGES PRESSURE INJECTABLE PERIPHERALLY INSCRTED CENTRAL CATHETER KITS. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Arrow International, Inc. (Reading, US). The FDA issued a Cleared decision on June 21, 2012 after a review of 227 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Arrow International, Inc. devices

FDA 510(k) Submission Details - K113277

510(k) Number K113277 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 2011
Decision Date June 21, 2012
Days to Decision 227 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 129d · This submission: 227d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 242
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K113277.
ARROW PICC POWERED BY ARROW VPS STYLET
K121941 · Arrow International (Subsidiary of Teleflex Inc.) · Sep 2012
NMI PICC III
K121089 · Navilyst Medical, Inc. · Aug 2012
PICC CONVENIENCE KIT
K121990 · Navilyst Medical, Inc. · Aug 2012
MEDCOMP VASCU-PICC & MIDLINE CATHETERS
K121094 · Medical Components, Inc. · Jun 2012
ARRW EVOLUTION
K112896 · Arrow International (Subsidiary of Teleflex Inc.) · May 2012
1.9F X 20CM VASCU-PICC 1.9F X 50CM VASCU-PICC
K120980 · Medical Components, Inc. · May 2012